Basit öğe kaydını göster

dc.contributor.authorŞahin, Orhan
dc.contributor.authorGenç, Simten
dc.contributor.authorÇetinkaya, Nur
dc.contributor.authorMihmanlı, Veli
dc.contributor.authorYıldırım, Gökhan
dc.contributor.authorTekirdağ, Ali İsmet
dc.date.accessioned2023-01-23T10:27:06Z
dc.date.available2023-01-23T10:27:06Z
dc.date.issued2022en_US
dc.identifier.citationŞahin, O., Genç, S., Çetinkaya, N., Mihmanlı, V., Yıldırım, G. ve Tekirdağ, A. İ. (2022). Duration of labor with meperidine versus placebo in singleton term pregnancies: A randomized placebo controlled study. European Archives of Medical Research, 38(1), 42-47. https://dx.doi.org/10.4274/eamr.galenos.2021.70783en_US
dc.identifier.issn2651-3137
dc.identifier.issn2651-3153
dc.identifier.urihttps://dx.doi.org/10.4274/eamr.galenos.2021.70783
dc.identifier.urihttps://hdl.handle.net/20.500.12511/10355
dc.description.abstractObjective: Meperidine, a synthetic opioid analgesic, is used empirically in many birth centers due to its effect on the duration of labor as well as pain relief during labor. In this study, we examine the effect of meperidine administration on the duration of labor. Methods: This study was designed as a prospective randomized placebo-controlled study; 250 patients were randomized into two groups where the study group received 0.5 mL-25 mg i.v. meperidine and the control group received 0.5 mL i.v. saline solution, all at the start of the active phase. The start of the active phase of labor was defined as 4 cm cervical dilatation and 60%-70% cervical effacement. The primary outcome was determined as the duration of the active phase (DAP). This study is registered on ClinicalTrials.gov (identifier: NCT01555671). Results: Women randomized to the meperidine group had a shorter total duration of labor (TDL) and shorter duration of the DAP compared to the control group, both in the total patient population women (mean ± standard deviation (SD): 273±129 min vs. 331±177 min, p=0.033; 249±122 min vs. 304±167 min, p=0.029, respectively) and in primiparous (mean ± SD: 372±134 min vs. 400±179 min, p=0.026; 296±126 min vs. 363±170 min, p=0.024, respectively). No statistically significant difference was found between the total patient population and primiparous group in terms of the second stage of labor (DSS) (p=0.930, p=0.229; respectively). Multiparous women in meperidine and control groups, did not show a statistically significant difference in terms of the TDL, DAP and the DSS (p=0.170, p=0.157, p=0.498; respectively). No statistically significant difference was found between the two study groups in terms of age (p=0.126), parity (p=0.427), body mass index (p=0.163), cesarean rates (p=0.511) and mean gestational weeks (p=0.845). Conclusion: Our findings revealed that meperidine administration was associated with a shorter duration of active phase of labor in primiparous women.en_US
dc.language.isoengen_US
dc.publisherGalenos Publishing Houseen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectActive Phaseen_US
dc.subjectApgaren_US
dc.subjectDuration Laboren_US
dc.subjectLabor Analgesiaen_US
dc.subjectMeperidineen_US
dc.subjectPethidinen_US
dc.titleDuration of labor with meperidine versus placebo in singleton term pregnancies: A randomized placebo controlled studyen_US
dc.typearticleen_US
dc.relation.ispartofEuropean Archives of Medical Researchen_US
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü, Kadın Hastalıkları ve Doğum Ana Bilim Dalıen_US
dc.authorid0000-0002-8717-8244en_US
dc.identifier.volume38en_US
dc.identifier.issue1en_US
dc.identifier.startpage42en_US
dc.identifier.endpage47en_US
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.identifier.doi10.4274/eamr.galenos.2021.70783en_US
dc.institutionauthorYıldırım, Gökhan
dc.identifier.trdizinid524896en_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster